dc.contributor.author | Hakki, Shilpa Anand | |
dc.date.accessioned | 2019-06-14T10:55:22Z | |
dc.date.available | 2019-06-14T10:55:22Z | |
dc.date.issued | 2018-05 | |
dc.identifier.citation | Journal of Evidence Based Medicine and Healthcare. 2018 May; 5(21): 1660-1663. | en_US |
dc.identifier.issn | 2349-2562, 2349-2570 | |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1276 | |
dc.language.iso | en | en_US |
dc.publisher | Level Up Business Center | en_US |
dc.subject | Non-steroidal anti-inflammatory drugs | en_US |
dc.subject | Acute kidney injury | en_US |
dc.subject | Chronic kidney disease | en_US |
dc.title | Pharmacoepidemiology | en_US |
dc.type | Article | en_US |